Literature DB >> 3159022

Aberrant neurofilament phosphorylation in Alzheimer disease.

N H Sternberger, L A Sternberger, J Ulrich.   

Abstract

Alzheimer tangles, despite their location in neuronal perikarya, react immunocytochemically with monoclonal antibodies to phosphorylated epitopes of neurofilaments. Normal perikarya do not contain phosphorylated neurofilaments. The aberrant phosphorylation in both plaques and tangles seems to be largely restricted to individual phosphorylation sites among the many sites available in neurofilaments. It is suggested that the Alzheimer lesion involves an imbalance within specific kinases responsible for phosphorylation of different sites in neurofilaments.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159022      PMCID: PMC397980          DOI: 10.1073/pnas.82.12.4274

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

2.  Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.

Authors:  G Perry; N Rizzuto; L Autilio-Gambetti; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Immunocytochemistry of brain-reactive monoclonal antibodies in peripheral tissues.

Authors:  E Ostermann; N H Sternberger; L A Sternberger
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

4.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.

Authors:  B H Anderton; D Breinburg; M J Downes; P J Green; B E Tomlinson; J Ulrich; J N Wood; J Kahn
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

5.  Ultrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle.

Authors:  H M Wisniewski; P A Merz; K Iqbal
Journal:  J Neuropathol Exp Neurol       Date:  1984-11       Impact factor: 3.685

6.  Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies.

Authors:  L A Sternberger; L W Harwell; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Multiple phosphorylation sites in mammalian neurofilament polypeptides.

Authors:  J P Julien; W E Mushynski
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

8.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Authors:  L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea.

Authors:  D J Selkoe; Y Ihara; F J Salazar
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

10.  Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies.

Authors:  C G Rasool; C Abraham; B H Anderton; M Haugh; J Kahn; D J Selkoe
Journal:  Brain Res       Date:  1984-09-24       Impact factor: 3.252

View more
  91 in total

1.  Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.

Authors:  M A Wrzolek; P A Merz; R Kascsak; I Grundke-Iqbal; K Iqbal; R Rubenstein; M Tonna-DeMasi; N L Goller; P Mehta; H M Wisniewski
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

2.  Filaments of Lewy bodies contain insoluble cytoskeletal elements.

Authors:  P G Galloway; P Mulvihill; G Perry
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

3.  Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells.

Authors:  G Sobue; Y Hashizume; T Yasuda; E Mukai; T Kumagai; T Mitsuma; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 4.  Tau pathology generated by overexpression of tau.

Authors:  I Grundke-Iqbal; K Iqbal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Abnormal processing of multiple proteins in Alzheimer disease.

Authors:  H Zhang; N H Sternberger; L J Rubinstein; M M Herman; L I Binder; L A Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Loss of neurofilament labeling in the primary visual cortex of monocularly deprived monkeys.

Authors:  Kevin R Duffy; Margaret S Livingstone
Journal:  Cereb Cortex       Date:  2004-11-24       Impact factor: 5.357

Review 7.  Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

8.  A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice.

Authors:  Varsha Shukla; Ya-Li Zheng; Santosh K Mishra; Niranjana D Amin; Joseph Steiner; Philip Grant; Sashi Kesavapany; Harish C Pant
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

9.  Acrylamide alters neurofilament protein gene expression in rat brain.

Authors:  H Endo; S Kittur; M I Sabri
Journal:  Neurochem Res       Date:  1994-07       Impact factor: 3.996

10.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.